Here are relevant reports on : ai-in-market-research

  • Direct conjugated antibodies are widely utilized in research and diagnosis, encompassing disciplines like immunology, cancer, and neuroscience. Direct conjugated antibodies are more in demand as a result of the increased prevalence of chronic diseases, rising R&D expenditures, and the requirement for precise diagnostics.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The global AI in life sciences market, valued at US$2.31B in 2023, is forecasted to grow at a 27.3% CAGR, reaching US$2.93B by 2024 and US$11.78B by 2030. Growth is driven by AI’s role in accelerating drug discovery, significantly reducing the time and cost of identifying and developing new therapies. The growing demand for personalized medicine drives the adoption since AI analyses complex datasets in order to provide customized treatment options.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • AI in Food & Beverage Market is projected to grow from USD XX billion in 2024 to USD XX billion by 2029, at a CAGR of XX% during the forecast period.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The AI Data Center market is projected to reach USD 100 billion by 2030 growing at a CAGR of 30%. Driven by major announcements and large-scale projects, the US leads with massive initiatives from OpenAI, AWS, Meta, and Microsoft, and others including the multi-hundred-billion-dollar Stargate project. India follows with AdaniConneX, ST Telemedia planning a multi-billion-dollar investments. The UK and Italy see strong investments from Microsoft, focusing on energy-efficient infrastructure, while South Korea’s SK Telecom and LG U+ adopt cutting-edge GPUs and cooling technologies. Saudi Arabia (KSA) also stands out with a 1.5 GW AI Inferencing Data Center that is planned to be built by Saudi Aramco and Groq

    • Published: March 2025
    • Price: $ 4950
    • TOC Available:
  • Intel Corporation (US), Siemens Healthcare GmbH (Germany), NVIDIA Corporation (US), Medtronic (Ireland), Amazon Web Services, Inc. (US), GE Healthcare (US), Metadvice Ltd. (UK), PathAI (US), Babylon Health (UK), AiCure (US), and Arterys (US) are few key players in the AI in clinical care market globally.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The Enterprise Agentic AI market is witnessing significant acceleration, with a projected market size increasing from USD 6.76 billion in 2025 to USD 46.04 billion by 2030, at a CAGR of 47% Asia-Pacific emerges as the fastest-growing region, fuelled by intensified enterprise automation focus and major government-backed digital initiatives across China and India. This accelerated activity highlights agentic AI's critical role in transforming market dynamics and driving operational efficiency worldwide.

    • Published: July 2025
    • Price: $ 4950
    • TOC Available:
  • Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.

    • Published: February 2025
    • Price: $ 4950
    • TOC Available:

Records 41 to 50 of 50

DMCA.com Protection Status